News

Insulin Degludec's Long Duration Sways FDA Panel

Publish date: November 8, 2012

 

AT A MEETING OF THE FOOD AND DRUG ADMINISTRATION ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE

The company also has submitted an application for approval of IDeg and IDegAsp in Europe, in Canada, and other countries. They were approved in Japan in late September.

UPDATED 11/12/12

Pages

Recommended Reading

Panel Supports Approval of Cholesterol Drug for Rare Disorder
MDedge Family Medicine
HbA1c Declines Cut 5-Year Death Rate
MDedge Family Medicine
Glucose Excursions Linked to Ventricular Tachycardia
MDedge Family Medicine
MI Rate Declines After Smoke-Free Laws Enacted in Olmsted County
MDedge Family Medicine
Weight Gain Following Diabetes Diagnosis Boosts Mortality
MDedge Family Medicine
Diabetes Deaths Decline in Tots and Teens
MDedge Family Medicine
FREEDOM: CABG Shows Excellent Cost Effectiveness
MDedge Family Medicine
AMG145 Delivers Robust Results for Statin-Intolerant Patients
MDedge Family Medicine
Practice Changer: CABG Bests Multivessel Stenting in Diabetes
MDedge Family Medicine
Aliskiren Didn't Protect Heart, Kidneys in Diabetes
MDedge Family Medicine